Altimmune Inc (ALT)
8.01
-0.89
(-10.00%)
USD |
NASDAQ |
May 17, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Altimmune Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.632M |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.1051M |
June 30, 2019 | 0.4166M |
March 31, 2019 | 0.5616M |
December 31, 2018 | 0.5728M |
September 30, 2018 | 2.012M |
June 30, 2018 | 1.895M |
March 31, 2018 | 0.6661M |
Date | Value |
---|---|
December 31, 2017 | 0.6496M |
September 30, 2017 | 0.6399M |
June 30, 2017 | 0.6202M |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.9846M |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.2495M |
March 31, 2015 | 0.4982M |
December 31, 2014 | 0.7461M |
September 30, 2014 | 0.9933M |
June 30, 2014 | 1.240M |
March 31, 2014 | 1.485M |
December 31, 2013 | 2.822M |
September 30, 2013 | 1.974M |
June 30, 2013 | 3.386M |
March 31, 2013 | 3.790M |
December 31, 2012 | 3.785M |
September 30, 2012 | 3.654M |
June 30, 2012 | 2.438M |
March 31, 2012 | 3.288M |
December 31, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
0.632M
Maximum
Jun 2020
0.0577M
Average
--
Median
Dec 2019
Total Long Term Debt (Quarterly) Benchmarks
Eli Lilly and Co | 26.21B |
Amgen Inc | 64.02B |
Pfizer Inc | 68.71B |
Viking Therapeutics Inc | -- |
GlycoMimetics Inc | -- |